Singapur - inglés - HSA (Health Sciences Authority)

vifor pharma asia pacific pte. ltd. - iron eqv iron sucrose - injection - 100 mg/5 ml - iron eqv iron sucrose 100 mg/5 ml

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr. falk pharma uk ltd - mesalazine - suppository - 1gram

Australia - inglés - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - iron sucrose, quantity: 540 mg/ml (equivalent: iron, qty 20 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - venofer is indicated for the treatment of iron deficiency anaemia in patients undergoing chronic haemodialysis and who are receiving supplemental erythropoietin therapy.,the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. serum ferritin, serum iron, transferrin saturation and hypochromic red cells).

Australia - inglés - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - patiromer sorbitex calcium, quantity: 33.6 g (equivalent: patiromer, qty 16.8 g) - powder, oral - excipient ingredients: xanthan gum - veltassa is indicated for the treatment of hyperkalaemia in adults.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - patiromer sorbitex calcium, quantity: 50.4 g (equivalent: patiromer, qty 25.2 g) - powder, oral - excipient ingredients: xanthan gum - veltassa is indicated for the treatment of hyperkalaemia in adults.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - patiromer sorbitex calcium, quantity: 16.8 g (equivalent: patiromer, qty 8.4 g) - powder, oral - excipient ingredients: xanthan gum - veltassa is indicated for the treatment of hyperkalaemia in adults.

Singapur - inglés - HSA (Health Sciences Authority)

vifor pharma asia pacific pte. ltd. - iron(iii)-hydroxide polymaltose complex 357mg eqv iron (iii) - tablet, film coated - iron(iii)-hydroxide polymaltose complex 357mg eqv iron (iii) 100mg

Australia - inglés - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - difelikefalin acetate, quantity: 55 microgram (equivalent: difelikefalin, qty 50 microgram) - injection, solution - excipient ingredients: sodium chloride; sodium acetate trihydrate; acetic acid; water for injections - korsuva is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - avacopan, quantity: 10 mg - capsule, hard - excipient ingredients: shellac; iron oxide yellow; titanium dioxide; iron oxide red; gelatin; potassium hydroxide; iron oxide black; peg-40 hydrogenated castor oil; macrogol 4000; polysorbate 80 - tavneos, in combination with a rituximab or cyclophosphamide based regimen, is indicated for the treatment of adults with anti-neutrophil cytoplasmic autoantibody (anca)-associated vasculitis (granulomatosis with polyangiitis [gpa] and microscopic polyangiitis [mpa]).

Arabia Saudí - inglés - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

universal pharmaceutical industries (unipharma) - ascorbic acid - effervescent tablet - 1 g